Making Hepatitis C A Rare Disease In The United States
New breakthrough medicines for Hepatitis C present an important choice about setting goals and taking systemic action to achieve public health advances in the United States. Despite appearing to offer cure rates greater than 90 percent, high-priced Hepatitis C drugs have driven treatment rationing since their approval over two years ago. Gaps in the screening, diagnosis, and treatment of Hepatitis C pose significant public health consequences. In May, the Centers for Disease Control and Prevention (CDC) identified Hepatitis C as the leading infectious killer in the United States in 2014—the first year in which new medicines for the disease were available—claiming more lives (nearly 20,000) than 60 other infectious diseases, including HIV/AIDS, pneumococcal disease, and tuberculosis, combined. However, recent steps have improved the prospects for many patients waiting for treatment. In March, the Veterans Affairs department announced access to Hepatitis C medicines for all patients regardless of disease stage. Last month, New York State Medicaid also lifted treatment restrictions. A newly organized Institute of Medicine committee on viral hepatitis proclaimed in its interim April report that the “elimination of hepatitis C as a public health problem in the United States is feasible.” Notably, the committee stopped short of setting a national goal for the elimination of Hepatitis C, as they continue to study the challenge for their final report due in 20...
Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have shown whether the therapy worked.
The start of the new school year is already proving that there is no one way to reopen schools during the Covid-19 pandemic and returning to classes does not mean anything close to returning to normal.
Vaccines protecting against influenza, hepatitis B and rabies are less effective for obese people. As scientists develop a Covid-19 vaccine, experts say obesity could be an impediment, a sobering prospect for the US, where nearly half of all adults are obese.
Stacey Nagy told CNN's Erin Burnett she wrote an obituary for her husband's coronavirus death where she blamed President Trump, Texas Gov. Abbott and those who do not wear masks because she felt a need to "put blame where it belonged."
Information for prisons and other prescribed places of detention on coronavirus (COVID-19). Recent updates: 4th August 2020 - added COVID-19 guidance for prisons and places of detention poster. 31st July 2020 - changed isolation period from 7 to 10 days.
Advice and information on how to look after your mental health and wellbeing during the coronavirus (COVID-19) outbreak. Update in this version (published 4th August 2020) - added translated documents in Arabic, Bengali, Chinese CN, Chinese HK, French, Gujarati, Polish, Portuguese, Punjabi and Urdu.
This is advice for parents and carers on looking after the mental health and wellbeing of children or young people during the coronavirus (COVID-19) outbreak. Update in this version (published 4th August 2020) - added translated documents in: Arabic, Bengali, Chinese CN, Chinese HK, French, Gujarati, Polish, Portuguese, Punjabi and Urdu.
Might HCV treatment have a role in mitigating the risk for developing chronic kidney disease among HIV/HCV co-infected individuals?AIDS
How does sustained virologic response from direct-acting antiviral and interferon-based treatments impact the risk of developing hepatocellular carcinoma?Journal of Viral Hepatitis
[Foroyaa] Unlike HIV/AIDS which is not transmitted by shaking hands, COVID-19 is highly contagious. Inhaling droplets while a person is coughing, sneezing or even talking, if those chatting are in closed, one could become infected. In the same vein, a person could transfer the virus through hand shake.
More News: Blogging | Blood Transusion | Cancer & Oncology | Carcinoma | Centers for Disease Control and Prevention (CDC) | Cirrhosis | Epidemics | Epidemiology | Funding | Government | Health | Health Medicine & Bioethics Commentators | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | HIV AIDS | Infectious Diseases | International Medicine & Public Health | Liver Cancer | Medicaid | Medicare | Outbreaks | Partnerships | Rare Diseases | Study | Tuberculosis | USA Health